Evidence-example-stroke-3-4half-alteplase-vs-no-alteplase-mRS0-2

Release 5 Ballot

This page is part of the FHIR Specification (v5.0.0-ballot: R5 Ballot - see ballot notes). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

Example Evidence/example-stroke-3-4half-alteplase-vs-no-alteplase-mRS0-2 (Narrative)

Clinical Decision Support Work Group

Maturity Level: N/A

Standards Status: Informative

Compartments: Not linked to any defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile Evidence.

"Effect of Alteplase vs No alteplase on mRS 0-2 at 90 days in Stroke 3-4.5 hours prior" is a comparative effect estimate.

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.